This year produced several significant rulings, but three decisions stood out because of their potential to significantly impact future product liability cases.
PLIVA Inc. v. Mensing, 131 S. Ct. 2657 (June 23, 2011): In 2009, the U.S. Supreme Court in Wyeth v. Levine held that approval by the Food and Drug Administration of a brand name drug did not pre-empt state law failure to warn cases. Bu...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In